Adero Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $669K | Buy |
1,380
+33
| +2% | +$16K | 0.04% | 110 |
|
|
2024
Q4 | $542K | Buy |
1,347
+5
| +0.4% | +$2.01K | 0.04% | 116 |
|
|
2024
Q3 | $624K | Buy |
1,342
+29
| +2% | +$13.5K | 0.04% | 109 |
|
|
2024
Q2 | $615K | Buy |
1,313
+37
| +3% | +$17.3K | 0.04% | 104 |
|
|
2024
Q1 | $533K | Buy |
1,276
+4
| +0.3% | +$1.67K | 0.04% | 109 |
|
|
2023
Q4 | $518K | Buy |
1,272
+68
| +6% | +$27.7K | 0.04% | 103 |
|
|
2023
Q3 | $419K | Buy |
+1,204
| New | +$419K | 0.04% | 117 |
|